Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
Emerging studies aim to better understand therapeutic interventions that may mitigate increased CVD risk in patients with RA.
Emerging studies aim to better understand therapeutic interventions that may mitigate increased CVD risk in patients with RA.
The realization that IL-6 is implicated in many pathologic features of RA has prompted the search for IL-6-blocking agents as therapeutic options for this condition.